Basing on the results of cell assays and animal trials, PDC-Cyp has a fascinating anti-cancer ability for HpG2 cells (human liver carcinoma cells), with almost neglectable side effects compared to Cyp-Y and HCQ [62]. The gene discussed is PPIG; the disease is hepatocellular carcinoma.